Payop unveils new player-first positioning and visual identity
Payop unveils new player-first positioning and visual identity Payop unveils new player-first positioning and visual identity Vancouver, Canada, British Columbia,…
Evinquo Launches Advanced Risk Management System for Real-Time Exposure Monitoring
PARIS, Dec. 22, 2025 (GLOBE NEWSWIRE) — Evinquo, a technology-driven financial solutions company, today announced the launch of its Advanced…
Kalmar to relocate and modify two STS cranes for Eurogate’s Wilhelmshaven terminal
Kalmar to relocate and modify two STS cranes for Eurogate’s Wilhelmshaven terminal Kalmar to relocate and modify two STS cranes…
Seize the Christmas Market Opportunities, Vince Trust Launches Bitcoin ETF Portfolio, Offering Daily Returns of Up to $3,548
LONDON, Dec. 22, 2025 (GLOBE NEWSWIRE) — With Christmas approaching, the global digital asset market is experiencing a year-end surge…
Meximodo Tequila Announces Launch of Meximodo Tequila Blanco, a Woman-Led Organic Tequila Brand
Jersey City, NJ, Dec. 22, 2025 (GLOBE NEWSWIRE) — Meximodo Tequila announced the launch of Meximodo Tequila Blanco, a premium…
ArcelorMittal expands its portfolio of renewable energy projects
Three new projects in India will bring the Company’s global renewable energy capacity to 3.3GW 22 December 2025, 08:30 CET…
Karolinska Development’s portfolio company SVF Vaccines plans for listing on Nasdaq First North Premier through reverse takeover ahead of accelerated vaccine development
STOCKHOLM, Sweden, December 22, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines has signed…
Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma
Introduction of AVT05 supported by NHS England tender award in the United Kingdom REYKJAVIK, ICELAND (December 22, 2025) — Alvotech…
THEON concludes a transformative 2025
THEON concludes a transformative 2025 Materially broadened and enhanced strategic platform, total backlog and options of c.€2.4 bn, secured supply…
WISeKey Issues Year-End CEO Letter to Shareholders
Geneva, Switzerland, December 22, 2025 – WISeKey International Holding Ltd (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity, blockchain,…
Ipsen expands early development pipeline with Simcere Zaiming’s innovative antibody drug conjugate
Ipsen gains exclusive global rights, outside of Greater China, for development, manufacturing and commercialization of SIM0613, a LRRC15-targeting antibody-drug conjugate…
FDA approves Roche’s Lunsumio VELO™ for subcutaneous use in relapsed or refractory follicular lymphoma
Lunsumio VELO reduces administration time from 2-4 hours to approximately one minute Availability of Lunsumio VELO allows treatment aligned to…
↑